SecFilingDex
DEF 14ACIK 0001402328

Sunshine Biopharma Inc. (SBFM, SBFMW)

Proxy statement (DEF 14A) filed .

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number
0001683168-26-008615
Filer
Sunshine Biopharma Inc. (SBFM, SBFMW)
CIK
0001402328
Form type
DEF 14A
Form description
Proxy statement
Filed at
November 12, 2026
Last verified
November 13, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Sunshine Biopharma Inc. (SBFM, SBFMW)

Provenance

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.